Related Experiment Videos
Roux-Y Gastric Bypass: an effective anti-reflux procedure
1Departments of Surgery and Medicine, Schumpert Medical Center and Physicians and Surgeons Hospital, Shreveport, LA 71101 USA.
Obesity Surgery
|September 1, 1991
Summary
Roux-Y gastric bypass (RYGBP) shows promise in treating reflux esophagitis and promoting weight loss. This bariatric surgery may offer superior symptom control compared to Nissen fundoplication for obese patients.
Area of Science:
- Gastroenterology
- Bariatric Surgery
- Digestive Health
Background:
- Gastric limiting procedures offer significant health improvements beyond weight loss.
- Reflux esophagitis can be effectively managed by reducing stomach acid secretion.
- Obesity is often comorbid with conditions like diabetes, hypertension, and arthritis.
Purpose of the Study:
- To compare the efficacy of Roux-Y gastric bypass (RYGBP) versus Nissen fundoplication in treating reflux esophagitis.
- To evaluate the impact of RYGBP on comorbid conditions and overall patient well-being.
- To assess the effectiveness of RYGBP in achieving sustained weight loss in obese patients.
Main Methods:
- A retrospective comparison of 100 obese patients with reflux esophagitis who underwent RYGBP.
- Comparison with a historical control group of 23 patients who underwent Nissen fundoplication.
- Assessment of symptom resolution using Visick grading and evaluation of weight loss outcomes.
Main Results:
- RYGBP achieved a 100% Visick grade I-II outcome for reflux esophagitis.
- Nissen fundoplication achieved an 87% Visick grade I-II outcome.
- RYGBP demonstrated potential superiority in symptom cure and sustained weight loss.
Conclusions:
- RYGBP may be a more effective procedure than Nissen fundoplication for obese patients with reflux esophagitis.
- RYGBP offers significant benefits including symptom resolution and weight management.
- Further statistically robust studies are warranted to confirm these findings.